logo
logo
Sign in

Neuromodulation Market Size Is Estimated To Grow at a CAGR of 11.2% By 2023 | Key Players, Emerging Trends, Dynamics and Share Analysis

avatar
rahul kumar
Neuromodulation Market Size Is Estimated To Grow at a CAGR of 11.2% By 2023 | Key Players, Emerging Trends, Dynamics and Share Analysis

The stimulus in question may be an electric current, a magnetic field, or a chemical drug.

This treatment is highly useful in treating conditions such as urinary and fecal incontinence, Alzheimer's disease, Parkinson's disease, epilepsy, and dystonia.

The geriatric population has grown rapidly in regions such as North America and Europe in recent years, leading to steady growth of the neuromodulation devices market.

Leading players in the global neuromodulation market includeSt.

Jude Medical Inc., Boston Scientific Corporation, Bioness Inc., Nevro Corporation, Synapse Biomedical Inc., Neuronetics Inc., BioControl Medical, DynaMD, Soterix Medical Inc., Accellent, Cyberonics Inc., Neurosigma Inc., NeuroPace Inc., EnteroMedics Inc., Aleva Neurotherapeutics SA, and LivaNova plc.

Based on type, the global neuromodulation market is classified as internal neuromodulation and external neuromodulation (non-invasive).Internal neuromodulation is further divided into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES).

collect
0
avatar
rahul kumar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more